Search Results:
CLINICAL TRIAL 17425
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 17431
A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared with Fluorouracil (5-FU) in Patients with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine
Disease Site: Colon, Liver, Lung, Other Endocrine System, Pancreas, Small Intestine, Stomach
View Trial DetailsCLINICAL TRIAL 17747
A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 17970
A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 18304
A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 18610
A Phase I-II Study of Triciribine Phosphate Monohydrate (PTX-200) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
Disease Site: Acute Leukemia (ALL, AML), Acute promyelocytic leukemia (APL), Chronic Leukemia (CLL, CML), Leukemia, other
View Trial DetailsCLINICAL TRIAL 18613
Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Disease Site: Ewing's sarcoma, Osteosarcoma, Rhabdomyosarcoma, Any Site
View Trial DetailsCLINICAL TRIAL 18741
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET): A Phase 3 Randomized Multicenter Trial to Compare Hepatic Progression-Free Survival Following Bland Embolization, Lipiodol Chemoembolization, and Drug-Eluting Bead Chemoembolization of Neuroendocrine Liver Metastases
Disease Site: Liver
View Trial DetailsCLINICAL TRIAL 18752
ACTION Trial- Adoptive Cellular Therapy following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I)
Disease Site: Brain and Nervous System, Gliomas
View Trial DetailsCLINICAL TRIAL 18959
A Phase 2 Study to Evaluate the Safety, Tolerability and Efficacy of Cell Transfer Therapy Using Autologous Tumor Infiltrating Lymphocytes (LN-145) followed by IL-2 in Patients with Recurrent and/or Metastatic Cervical Carcinoma
Disease Site: Cervix
View Trial DetailsCLINICAL TRIAL 18989
A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination with Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 18994
Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing
Disease Site: Head & Neck, Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 19117
A Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients with HER-2 Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 19125
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Disease Site: Cervix, Other Female Genital, Vaginal
View Trial DetailsCLINICAL TRIAL 19137
A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 19319
InPACT- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Disease Site: Penis / penile cancer, Other Male Genital
View Trial DetailsCLINICAL TRIAL 19327
A Phase 2 Trial of Pembrolizumab Plus Bevacizumab in Patients with Metastatic Melanoma or Non-small Cell Lung Cancer with Untreated Brain Metastases
Disease Site: Non small cell lung cancer, Brain and Nervous System, Lung, Melanoma, skin, Gliomas
View Trial DetailsCLINICAL TRIAL 19365
Phase 1 Trial of the LSD1 Inhibitor Seclidemstat (SP 2577) with and without Topotecan and Cyclophosphamide in Patients with Relapsed or Refractory Ewing Sarcoma and Select Sarcomas
Disease Site: Ewing's sarcoma, Any Site
View Trial DetailsCLINICAL TRIAL 19387
A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer, (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20)
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 19389
A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Subjects with Advanced Non-Small Cell Lung Cancer
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 19414
A Phase 2 Study of Talimogene Laherparepvec (T-VEC) and Radiation in Localized Soft Tissue Sarcoma
Disease Site: Soft Tissue
View Trial DetailsCLINICAL TRIAL 19429
A Phase 2 Single-Arm, Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax in Combination with Ruxolitinib in Subjects with Myelofibrosis
Disease Site: Myelofibrosis, Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 19435
Combination of Nivolumab Immunotherapy with Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 19441
Pilot Study of Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 19456
Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
Disease Site: Acute Leukemia (ALL, AML), Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 19481
Phase I, Open Label Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Expansion, Persistence and Clinical Activity of UCART123 (Allogeneic Engineered T Cells Expressing anti-CD123 Chimeric Antigen Receptor), Administered in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Disease Site: Acute Leukemia (ALL, AML), Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 19487
A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with Azacitidine in Patients with Recurrent, Resectable Osteosarcoma
Disease Site: Any Site, Osteosarcoma
View Trial DetailsCLINICAL TRIAL 19495
A Multicenter, Randomized, Double Blinded, Placebo Controlled, Phase 3 trial of Adjuvant Avelumab (anti PDL1 antibody) in Merkel Cell Carcinoma Patients with Clinically Detected Lymph Node Metastases
Disease Site: Merkel cell carcinoma (neuroendocrine skin cancer), Other Skin
View Trial DetailsCLINICAL TRIAL 19570
A Phase II Trial of Pembrolizumab and Cabozantinib in Patients with RM SCCHN
Disease Site: Head & Neck, Other Endocrine System
View Trial DetailsCLINICAL TRIAL 19579
Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy Fractionation for Patients with HPV+ Oropharyngeal Cancers.
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 19580
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 in Patients with Advanced Solid Tumors
Disease Site: Any Site, Sarcoma
View Trial DetailsCLINICAL TRIAL 19627
A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Complete Remission
Disease Site: Lymphoma, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 19635
A Phase 1b/2 Study Evaluating the Safety and Efficacy of Intravenous LB-100 in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) who had Disease Progression or are Intolerant to Prior Therapy
Disease Site: Leukemia, other, Myelodysplastic syndrome (MDS)
View Trial DetailsCLINICAL TRIAL 19646
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 19656
Phase I Study of Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 19658
A Phase 1, Open-Label, Dose-Escalation with Expansion Study of SX-682 in Subjects with Myelodysplastic Syndrome Who Had Disease Progression or are Intolerant to Prior Therapy
Disease Site: Myelodysplastic syndrome (MDS), Leukemia, other
View Trial DetailsCLINICAL TRIAL 19683
A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of RMC-4630 Monotherapy in Adult Participants with Relapsed/Refractory Solid Tumors
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 19694
Phase II Study of Nivolumab and Ramucirumab for Patients with Previously-Treated Mesothelioma
Disease Site: Mesothelioma, Lung
View Trial DetailsCLINICAL TRIAL 19715
An Open-Label, Randomized, Multicenter, Phase Ib/II Trial Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Mosunetuzumab (Btct4465a) In Combination With Polatuzumab Vedotin In Patients With B-Cell Non-Hodgkin Lymphoma
Disease Site: Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 19722
A Phase 2, Multi-Cohort, Open-Label, Multicenter Study To Determine The Efficacy And Safety Of Bb2121 In Subjects With Relapsed And Refractory Multiple Myeloma And In Subjects With High-Risk Multiple Myeloma Having Progressed Within One Year Of Initial Treatment
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 19732
Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus (Cabinet)
Disease Site: Neuroendocrine, Other Endocrine System
View Trial DetailsCLINICAL TRIAL 19742
Phase 1/1b Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 19748
Phase II Randomized Trial of Radiotherapy with Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients with Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN Trial)
Disease Site: Head & Neck, Squamous Cell Carcinoma (SCC), Lip, Oral Cavity and Pharynx, Other Skin
View Trial DetailsCLINICAL TRIAL 19776
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 Alone and in Combination with Nivolumab in Patients with Advanced Solid Tumors
Disease Site: Any Site, Bones and Joints, Breast, Esophagus, Larynx, Lung, Other Respiratory and Intrathoracic Organs, Soft Tissue
View Trial DetailsCLINICAL TRIAL 19819
Phase II Randomized Trial of Neo-Adjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Disease Site: Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 19829
A Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate the Safety and Clinical Activity of PBCAR0191 in Subjects with Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Disease Site: Lymphoid Leukemia, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 19862
A Phase 1/1b Safety Study of PRGN-3006 Adoptive Cellular Therapy in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome
Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS), Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 19867
A Phase 1b/2 Study of BXCL701, a Small Molecule Inhibitor of Dipeptidyl Peptidases (DPP), Administered in Combination with the Anti-Programmed Cell Death 1 (PD-1) Monoclonal Antibody Pembrolizumab (PEMBRO; Keytruda®) in Patients with Small Cell Neuroendocrine Prostate Cancer (SCNC; NEPC)
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 19873
A Phase II Open Label Single Arm Study of Adjuvant Nivolumab following Chemo-Radiation in localized Muscle-Invasive Bladder Cancer (NEXT)
Disease Site: Urinary Bladder
View Trial DetailsCLINICAL TRIAL 19940
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients with Recurrent Small Cell Lung Cancer: Big Ten Cancer Research Consortium BTCRC-LUN17-127
Disease Site: Small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 19942
Sequential Maintenance with Thoracic Radiotherapy and Durvalumab (MEDI4736) monotherapy or Durvalumab (MEDI 4736) combinations (Tremelimumab or Olaparib) in patients with Extensive Stage-Small Cell Lung Cancer after first line Platinum-based Chemotherapy
Disease Site: Lung, Small cell lung cancer
View Trial DetailsCLINICAL TRIAL 19948
A Phase 2 Study of Atezolizumab and Cobimetinib in PD-1/PD-L1 Inhibitor Resistant or Refractory Non-Small Cell Lung Cancer
Disease Site: Non small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 19967
A Phase I, Multi-Center, Open-Label, Treatment Duration Increment, Expansion, Safety, and Pharmacodynamic Study of CX-4945 Administered Orally Twice Daily to Patients with Advanced Basal Cell Carcinoma
Disease Site: Skin, Other Skin
View Trial DetailsCLINICAL TRIAL 19981
A Randomized Phase II Study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma
Disease Site: Urinary Bladder, Urothelial Cancer
View Trial DetailsCLINICAL TRIAL 19988
A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy
Disease Site: Urothelial Cancer, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 19989
Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer
Disease Site: Pancreas
View Trial DetailsCLINICAL TRIAL 20026
A Phase I Study of NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD1 Therapy
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20030
A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node or T3N0 Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20040
A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma
Disease Site: Merkel cell carcinoma (neuroendocrine skin cancer), Other Skin
View Trial DetailsCLINICAL TRIAL 20042
CD8 Depleted, Non-Engrafting, HLA Mismatched Unrelated Donor Lymphocyte Infusion in Patients with MDS and Secondary AML
Disease Site: Acute Leukemia (ALL, AML), Myelodysplastic syndrome (MDS), Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20050
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination with ALT-803 in Patients with BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Disease Site: Urinary Bladder
View Trial DetailsCLINICAL TRIAL 20056
Phase II Clinical Trial of Green Tea Catechins in Men on Active Surveillance (AS)
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 20073
A Phase II Study of Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) after Allogeneic Hematopoietic Cell Transplantation (HCT)
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 20089
A Phase 1b, Multicenter, Two-Part, Open label Study Of Trastuzumab Deruxtecan, An Anti-Human Epidermal Growth Factor Receptor-2 (HER2)-Antibody Drug Conjugate (ADC), In Combination With Pembrolizumab, An Anti PD-1 Antibody, In Subjects With Locally Advanced/Metastatic Breast Or Non-Small Cell Lung Cancer (NSCLC)
Disease Site: Breast, Lung
View Trial DetailsCLINICAL TRIAL 20110
GBM Agile: Global Adaptive Trial Master Protocol
Disease Site: Brain and Nervous System
View Trial DetailsCLINICAL TRIAL 20113
Phase 1/2 FIH Study of Regn5458 (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Patients with Relapsed or Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20117
A Phase 1/2 Study of Regn5678 (Anti-psmaxcd28) with Cemiplimab (Anti-pd-1) in Patients with Metastatic Castration-Resistant Prostate Cancer
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 20130
Phase II Study of Daratumumab Based Response Adapted Therapy for Older Adults with Newly Diagnosed Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20131
Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning for Transplantation of HLA-Haploidentical Related Hematopoietic Cells (Haplo-HCT) For Patients With Hematologic Malignancies
Disease Site: Other hematologic, Hodgkin's Lymphoma, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20132
Phase 1/2 Dose-Escalation and Expansion Study of FLX475 Alone and in Combination with Pembrolizumab in Advanced Cancer
Disease Site: Any Site, Breast, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 20141
A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20144
A Phase 1, First-in-Human, Open-Label, Dose Escalation and Expansion Study of CUE-101 Monotherapy in Second Line and CUE-101 Combination Therapy with Pembrolizumab in First Line Patients with HPV16+ Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Disease Site: Head & Neck, Larynx, Lip, Oral Cavity and Pharynx, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20145
A Pilot Study of Intratumorally and Intraparenchymally Administered OS2966 using Convection-enhanced Delivery in Patients with Recurrent/Progressive High-grade Glioma Undergoing a Clinically-indicated Surgical Resection
Disease Site: Brain and Nervous System, Gliomas
View Trial DetailsCLINICAL TRIAL 20149
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients with Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 20159
A Phase 1 Study of ZW49 in Patients with Locally Advanced (Unresectable) or Metastatic HER2-Expressing Cancers
Disease Site: Esophagus, Breast
View Trial DetailsCLINICAL TRIAL 20162
Phase 1 Trial of Intralesional Immunotherapy with IFx-Hu2.0 Vaccine in Patients with Advanced Merkel Cell Carcinoma or Cutaneous Squamous Cell Carcinoma
Disease Site: Melanoma, skin, Merkel cell carcinoma (neuroendocrine skin cancer), Other Skin, Skin, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20163
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non©\Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature©\driven Analysis
Disease Site: Non small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 20174
A Phase I, Open-Label, Dose Finding Study To Assess The Safety, Tolerability, Pharmacokinetics, And Preliminary Efficacy Of OBT076, A CD205-Directed Antibody-Drug Conjugate, In Recurrent And/Or Metastatic CD205 Positive Solid Tumors And In Women With CD205 Positive HER2-Negative Metastatic Breast Cancer
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 20178
An Open-Label Randomized Phase II Study of Combining Osimertinib with and without Ramucirumab in TKI-naïve EGFR-mutant Locally Advanced or Metastatic NSCLC
Disease Site: Non small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 20251
A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (SPEARHEAD 1 Study)
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 20253
Open Label, Multi-Center, Phase 1b Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20270
A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-144 or LN-145) in Patients with Solid Tumors (IOV-COM-202)
Disease Site: Lung, Melanoma, skin, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20274
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
Disease Site: Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 20282
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16 Positive, Non-Smoking Associated Oropharyngeal Cancer
Disease Site: Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 20285
A Multicenter Phase I/II Trial of a Novel MDM2 Inhibitor (APG-115) in P53 Wild-Type Salivary Gland Carcinoma
Disease Site: Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 20287
A Phase 1b/2 Study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20304
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (Codebreak 100)
Disease Site: Non small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 20305
Phase 1/1b Trial of Donor gamma delta T-cell Infusion for Treatment of Patients with Acute Myeloid Leukemia at High Risk of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20313
Neoadjuvant Immunotherapy with Intratumoral Tavokinogene Telseplasmid (Tavo) plus Electroporation in Combination with Intravenous Nivolumab in Patients with Operable Locally- Regionally Advanced Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20336
A Phase II Trial of Ribociclib (LEE011) plus Letrozole in Women with Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum
Disease Site: Ovarian, Ovary, Reproductive System
View Trial DetailsCLINICAL TRIAL 20339
Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma
Disease Site: Rhabdomyosarcoma, Bones and Joints
View Trial DetailsCLINICAL TRIAL 20345
Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) or Photon (IMRT) with Simultaneously Integrated Boost to the High Margin for Retroperitoneal Sarcomas
Disease Site: Anal, Colon, Kidney, Other genitourinary, Pancreas, Rectum, Sarcoma
View Trial DetailsCLINICAL TRIAL 20349
A Phase 2 Study of TAS-120 in Metastatic Breast Cancers Harboring Fibroblast Growth Factor Receptor (FGFR) Amplifications
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20353
S1806, Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Disease Site: Urinary Bladder
View Trial DetailsCLINICAL TRIAL 20361
A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As A Single Agent In Relapsed Or Refractory Hematological Malignancies and In Combination With Daratumumab As A Salvage Regimen for Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20364
A Phase 1/2 Study of REGN5093 in Patients with Met-Altered Advanced Non-Small Cell Lung Cancer
Disease Site: Non small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 20373
TH-138: Phase II Randomized Trial of Carboplatin + Pemetrexed + Bevacizumab, With or Without Atezolizumab in Stage IV Non-Squamous NSCLC Patients who Harbor a Sensitizing EGFR Mutation or Have Never Smoked
Disease Site: Non small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 20377
A Phase 2 Multicohort Study of Nivolumab in Combination with Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone Sensitive Prostate Cancer Patients with DNA Damage Repair Defects or Inflamed Tumors
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 20385
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin(Adcetris) Plus AVD in Patients (Age >/= 12 years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Disease Site: Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20409
A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-Tumor Efficacy of DZD9008 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR or HER2 Mutation
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20415
A Phase III, Open-Label, Multicenter, Randomized Study Evaluating The Safety And Efficacy Of Polatuzumab Vedotin In Combination With RituximabI Plus Gemcitabine Plus Oxaliplatin (R-Gemox) Versus R-Gemox Alone In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20419
Phase II Study of Short Course FOLFOX Chemotherapy with Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
Disease Site: Esophagus, Other Digestive Organ
View Trial DetailsCLINICAL TRIAL 20484
A Phase 2 Study of Donor-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-401) Administered to Patients with Acute Myeloid Leukemia (AML) following Hematopoietic Stem Cell Transplantation
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20490
Keystroke: A Randomized Phase II Study of Pembrolizumab (Keytruda) Plus Stereotactic Re-irradiation versus SBRT Alone For Locoregionally Recurrent or Second Primary Head and Neck Carcinoma
Disease Site: Other Skin
View Trial DetailsCLINICAL TRIAL 20491
A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 Antitrypsin (AAT) Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD Following Allogeneic Hematopoietic Stem Cell Transplant
Disease Site: Graft vs Host Disease (GVHD), Unknown Sites
View Trial DetailsCLINICAL TRIAL 20494
A Phase II Study of High Dose Bolus IL2 in Combination with Low Dose Ipilimumab Followed Sequentially by Nivolumab in Patients with Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20520
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of AMG 757 in Subjects with Small Cell Lung Cancer
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20530
Multicenter, Phase II, Neoadjuvant and Adjuvant Study of Alectinib, Entrectinib, or Vemurafenib Plus Cobimetinib in Patients with Stages I-III Non-Small Cell Lung Cancer with ALK, ROS1, NTRK, or BRAF V600E Molecular Alterations
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20552
A Phase 1b/2 Study Evaluating the Safety and Efficacy of Canakinumab with Darbepoetin alfa in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) who have Failed Erythropoietin Stimulating Agents (ESA)
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20562
A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination with RP1 in Patients with Advanced Cutaneous Squamous Cell Carcinoma
Disease Site: Other Skin, Skin, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20571
Optimizing Cellular and Humoral Immunity to Pneumococcus by Vaccination with Pneumococcal 13-valent conjugate vaccine before and after CD19-targeted CAR T-cell Immunotherapy
Disease Site: Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20578
A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmocodynamics of ALLO-501A, an Anti-CD19 Allogeneic Car T Cell Therapy in Subjects with Relapsed/Refractory Large B-Cell Lymphoma (LBCL)
Disease Site: Lymphoma, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20579
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20592
An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia
Disease Site: Leukemia, other, Acute Leukemia (ALL, AML)
View Trial DetailsCLINICAL TRIAL 20608
A Phase 1/2 Study Evaluating the Safety and Efficacy of IOV-2001 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Disease Site: Chronic Leukemia (CLL, CML), Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20631
Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20637
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS (FSRS) for Resected Metastatic Brain Disease
Disease Site: Brain and Nervous System, Brain metastasis
View Trial DetailsCLINICAL TRIAL 20641
A Randomized Pilot Trial of Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib and Binimetinib in Advanced Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20711
A Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
Disease Site: Urinary Bladder
View Trial DetailsCLINICAL TRIAL 20712
A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV- Associated Solid Tumors, with Expansion Cohorts in HIV-Associated Solid tumors and a Cohort of HIV- Associated Classical Hodgkin Lymphoma
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20716
ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome
Disease Site: Leukemia, other
View Trial DetailsCLINICAL TRIAL 20720
S1827, MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Disease Site: Small cell lung cancer, Lung
View Trial DetailsCLINICAL TRIAL 20722
Phase III Randomized Trial of Pleurectomy/Decortication plus Chemotherapy with or without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM)
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20731
Phase 2 Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
Disease Site: Other Skin, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 20733
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzomab Ozogamicin (a conjugated anti-CD22 monoclonal antibody) to Frontline Therapy in Young Adults (ages 18-39 years) with Newly Diagnosed Precusor B-cell ALL
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20737
Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel That is Nonconforming for Commercial Release
Disease Site: Hodgkin's Lymphoma, Lymphoid Leukemia, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20751
A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma
Disease Site: Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20753
An Open-Label Phase I, Multi-Center Study to Determine the Recommended Dose of the Chimeric Antigen Receptor T-cell Treatment CYAD-211 After a Non-Myeloablative Preconditioning Chemotherapy in Multiple Myeloma Patients with Relapsed or Refractory Disease (IMMUNICY-1)
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20760
Open-Label, Multicenter, Phase 1b /2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous Anti-claudin18.2 Chimeric Antigen Receptor T-cell Therapy in Subjects with Advanced Gastric, Pancreatic, or Other Specified Digestive System Cancers
Disease Site: Pancreas, Stomach
View Trial DetailsCLINICAL TRIAL 20767
Integration of Immunotherapy into Adjuvant Therapy For Resected NSCLC: Alchemist Chemo-IO
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20772
An Open-label Phase 1b/2a Study of NT-I7 (efineptakin alfa) in Combination with Pembrolizumab in Subjects with Relapsed/Refractory Advanced Solid Tumors
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 20773
Neoadjuvant Lenvatinib Plus Pembrolizumab in Resectable Merkel Cell Carcinoma
Disease Site: Merkel cell carcinoma (neuroendocrine skin cancer), Other Skin
View Trial DetailsCLINICAL TRIAL 20781
A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma (CARTITUDE-2)
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20794
Neoadjuvant Cemiplimab in Stage I-II Merkel Cell Carcinoma: Safety and Biomarker Analysis
Disease Site: Other Skin
View Trial DetailsCLINICAL TRIAL 20814
Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Adult T-Cell Leukemia/Lymphoma: A Pilot Study of the Rare Lymphoma Working Group
Disease Site: Leukemia, other
View Trial DetailsCLINICAL TRIAL 20821
A Phase 1 Study of REGN6569, an Anti-GITR mAB, with Cemiplimab in Patients with Advanced Solid Tumor Malignancies
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 20825
A First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors
Disease Site: Other Digestive Organ, Bile Duct Cancer / Cholangiocarcinoma
View Trial DetailsCLINICAL TRIAL 20826
S1701, A Randomized Phase II Trial of Carboplatin-Paclitaxel with or without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20827
An Open-Label, Multi-Center Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T cells in Patients with Advanced Non-Small Cell Lung Cancer (CHIRON)
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20832
A Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization in Patients with Localized Prostate Carcinoma and Obstructive Lower Urinary Tract Symptoms
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 20840
An Exploratory, Open-label, Multicenter Phase 1b Trial to Evaluate Safety and Efficacy of Sym021 (Anti-PD-1) in Combination with Either Sym022 (Anti-LAG-3) or Sym023 (Anti-TIM-3) or Sym023 and Irinotecan in Patients with Recurrent Advanced Biliary Tract Carcinomas
Disease Site: Liver, Lung, Other Female Genital, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 20848
Phase I/II Study of REGN5668 (MUC16 x CD28, A Costimulatory Bispecific) Administered In Combination With Cemiplimab or REGN4018 (MUC16 x CD3)
Disease Site: Other Female Genital, Ovary
View Trial DetailsCLINICAL TRIAL 20854
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Disease Site: Melanoma, skin, Other Skin
View Trial DetailsCLINICAL TRIAL 20862
A Phase 1 Study of SRF617 in Patients with Advanced Solid Tumors
Disease Site: Other Digestive Organ
View Trial DetailsCLINICAL TRIAL 20870
Pilot Study to Assess the Efficacy of Aspirin to Improve Immunological Features of Ovarian Tumors
Disease Site: Other Female Genital, Ovary
View Trial DetailsCLINICAL TRIAL 20871
A Phase 3, Open-label, Randomized, Multicenter Study of Ravulizumab in Adult and Adolescent Participants who have Thrombotic Microangiopathy (TMA) after Hematopoietic Stem Cell Transplant (HSCT)
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 20873
A Phase 1b, Open-Label Study of Relacorilant in Combination with Pembrolizumab for Patients with Adrenocortical Carcinoma with Excess Glucocorticoid Production
Disease Site: Adrenal, Adrenalcortical cancer
View Trial DetailsCLINICAL TRIAL 20877
A Phase Ib /Randomized Phase III Trial of Patients with Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation with Either Orca-T, a T-cell-Depleted Graft with Additional Infusion of Conventional T cells and Regulatory T cells, or Standard-of-Care Allogeneic Graft
Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20883
A Phase 1 Study of MLN4924 (pevonedistat) and Belinostat in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20894
Acalabrutinib for Chronic Graft-versus-Host Disease
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 20898
A Modular Phase 2a Multicentre Open-Label Study to Investigate DNA-damage Response Agents (or Combinations) in Patients With Advanced Cancer Whose Tumours Contain Molecular Alterations (PLANETTE)
Disease Site: Any Site, Breast, Colorectal, Endometrial/Uterine, Extrapulmonary small cell lung cancer, Gallbladder, Gastric / Stomach, Gastrinoma, Gastrointestinal, Liver, Lung, Non small cell lung cancer, Other genitourinary, Other GI, Pancreas, Prostate, Reproductive System, Urinary Bladder, Uterus
View Trial DetailsCLINICAL TRIAL 20899
Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases
Disease Site: Brain and Nervous System, Breast
View Trial DetailsCLINICAL TRIAL 20902
A Phase I Trial of Capecitabine in Combination with Cemiplimab in Patients with Hormone Receptor Positive Metastatic Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20903
A Phase II, Open-label, Multicenter, International Study of Durvalumab Following Radiation Therapy in Patients with Stage III, Unresectable Non-Small Cell Lung Cancer Who Are Ineligible for Chemotherapy (DUART)
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20904
A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab vs Ipilimumab + Nivolumab in Braf-V600 Mutant Melanoma with Brain Metastases
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 20909
An Open-label Phase 1/1b Study to Evaluate the Safety and Pharmacokinetics of JNJ-73841937 (Lazertinib), a Third Generation EGFR-TKI, as Monotherapy or in Combinations With JNJ-61186372, a Human Bispecific EGFR and cMet Antibody in Participants with Advanced Non-Small Cell Lung Cancer
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20911
MRI Guided Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma to Enhance Complete Response
Disease Site: Rectum
View Trial DetailsCLINICAL TRIAL 20915
A Phase II Study of HER2 directed Dendritic Cell (DC1) vaccine Plus Weekly Paclitaxel, Trastuzumab and Pertuzumab in Patients with HER-2 Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20919
An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases
Disease Site: Other Hematopoietic
View Trial DetailsCLINICAL TRIAL 20923
A Phase I/II Trial of Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 20936
DuRvalumab (MEDI4736) with ChEmotherapy as First Line TreAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
Disease Site: Lung, Mesothelioma
View Trial DetailsCLINICAL TRIAL 20938
A Randomized Phase II Trial of Adjuvant Pembrolizumab Versus Observation Following Curative Resection for Stage I Non-Small Cell Lung Cancer (NSCLC) with Primary Tumors Between 1-4 cm
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20939
A Phase 1b/2 Open Label Umbrella Study of Sasanlimab Combined With Anti-Cancer Therapies Targeting Multiple Molecular Mechanisms in Participants with Non-Small Cell Lung Cancer (NSCLC)
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20943
Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
Disease Site: Other Urinary, Urinary Bladder, Urothelial Cancer
View Trial DetailsCLINICAL TRIAL 20950
A Phase I/II, Open Label, Multi-center, Non-randomized Dose Escalation and Dose Expansion Study of AMXI-5001 in Patients with Advanced Malignancies
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 20951
A Phase 1 Study of Oral LY3410738 in Patients with Advanced Hematologic Malignancies with IDH1 or IDH2 Mutations
Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Other Hematopoietic
View Trial DetailsCLINICAL TRIAL 20956
A Two-Part, Phase 1a/B, Open-Label, Multicenter Trial Evaluating Pharmacokinetics, Safety and Efficacy Of PF-07284890 (ARRY-461) In Participants With BRAF V600-Mutant Solid Tumors With And Without Brain Involvement
Disease Site: Any Site, Brain and Nervous System, Larynx, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Other Skin, Brain metastasis, Gliomas
View Trial DetailsCLINICAL TRIAL 20963
A Phase 2 Study of Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20964
A Phase 2 Basket Study of Tucatinib in Combination with Trastuzumab in Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations
Disease Site: Brain and Nervous System, Breast, Ill-Defined Sites, Lung, Other Digestive Organ, Urinary Bladder, Brain metastasis, Leptomeningeal (LMD)
View Trial DetailsCLINICAL TRIAL 21022
A Phase 1b/2, Master Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 (pINN sotorasib) in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation
Disease Site: Any Site, Brain and Nervous System, Lung, Pancreas, Rectum, Brain metastasis, Leptomeningeal (LMD)
View Trial DetailsCLINICAL TRIAL 21026
A Phase II Study of Cemiplimab, an Anti-PD-1 Monoclonal Antibody, and ISA101b Vaccine in Patients with Recurrent/Metastatic HPV16 Positive Oropharyngeal Cancer who have Experienced Disease Progression with Prior Anti-PD-1 Therapy
Disease Site: Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21027
A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Metastatic Non-Small-Cell Lung Cancer
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 21028
A Randomized, Open-label Phase 3 Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared with Carboplatin-Pemetrexed, in Patients with EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 21029
A Multicenter Phase II Trial of Paclitaxel with and without Nivolumab in Taxane Naïve, and Nivolumab and Cabozantinib in Taxane Pre-treated Subjects with Angiosarcoma
Disease Site: Any Site, Soft Tissue
View Trial DetailsCLINICAL TRIAL 21035
A Pilot Study of Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
Disease Site: Lymphoid Leukemia
View Trial DetailsCLINICAL TRIAL 21038
GRECO-2: A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer
Disease Site: Pancreas
View Trial DetailsCLINICAL TRIAL 21039
A Pivotal Randomized, Open-Label Study Of OPTUNE(R)(TTFIELDS, 200KHZ) Concomitant With Radiation Therapy And Temozolomide For The Treatment Of Newly Diagnosed Glioblastoma
Disease Site: Brain and Nervous System, Gliomas
View Trial DetailsCLINICAL TRIAL 21046
Phase I Trial with Expansion Cohort of Obp-301 (Telomelysintm) And Definitive Chemoradiation For Patients with Locally Advanced Esophageal And Gastroesophageal Adenocarcinoma Who Are Not Candidates For Surgery
Disease Site: Esophagus
View Trial DetailsCLINICAL TRIAL 21056
A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia
Disease Site: Lymphoid Leukemia
View Trial DetailsCLINICAL TRIAL 21057
A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 21063
A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y-90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC)
Disease Site: Liver
View Trial DetailsCLINICAL TRIAL 21074
A Phase 2 Randomized Study of Osimertinib Versus Osimertinib Plus Chemotherapy for Patients with Metastatic EGFR-Mutant Lung Cancers That Have Detectable EGFRMutant cfDNA in Plasma After Initiation of Osimertinib
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 21077
A Phase 2 Study of ALX148 in Combination with Pembrolizumab in Patients with Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21078
A Phase 2 Study of ALX148 in Combination with Pembrolizumab and chemotherapy in Patients with Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21080
A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SRK-181 Administered Alone or in Combination with a Checkpoint Inhibitor in Patients with Locally Advanced or Metastatic Solid Tumors (DRAGON)
Disease Site: Any Site, Lung, Melanoma, skin, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 21083
A Phase 2b Randomized Trial of Autologous Dendritic Cell Immunotherapy (CMN-001) Plus Standard Treatment of Advanced Renal Cell Carcinoma
Disease Site: Other
View Trial DetailsCLINICAL TRIAL 21084
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1PI
Disease Site: Brain and Nervous System, Gliomas
View Trial DetailsCLINICAL TRIAL 21089
Phase 2, Single-arm, Open-label Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer with Actionable Genomic Alterations and Progressed On or After Kinase Inhibitor Therapy and Platinum-based Chemotherapy (TROPION-Lung05)
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 21090
A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
Disease Site: Myelodysplastic syndrome (MDS), Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 21094
An Open Label, Multi-Cohort, Multi-Center Phase II Study Evaluating the Efficacy and Safety of IPH4102 Alone or in Combination with Chemotherapy in Patients with Advanced T-cell Lymphoma
Disease Site: Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 21096
A Phase I Study of Duvelisib in Combination with CC-486 in Lymphoid Malignancy
Disease Site: Lymphoid Leukemia, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 21112
Phase 2 Study of Axitinib + Ipilimumab in Advanced Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 21113
A Phase I Clinical Trial of an Infusion of Autologous T Cells Genetically Engineered with a Chimeric Receptor to Target the Follicle-Stimulating Hormone Receptor in Patients with Recurrent Ovarian Cancer
Disease Site: Ovary
View Trial DetailsCLINICAL TRIAL 21114
AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy
Disease Site: Graft vs Host Disease (GVHD), Unknown Sites
View Trial DetailsCLINICAL TRIAL 21116
Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)
Disease Site: Larynx, Lip, Oral Cavity and Pharynx, Head & Neck, Squamous Cell Carcinoma (SCC)
View Trial DetailsCLINICAL TRIAL 21117
A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ALLO-316 Following ALLO-647 Containing Conditioning Regimen in Subjects with Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)
Disease Site: Kidney
View Trial DetailsCLINICAL TRIAL 21119
A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Alone and In Combination with Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
Disease Site: Ovary
View Trial DetailsCLINICAL TRIAL 21122
A Multicenter, Phase 1, Open-label, Dose-escalation and Expansion Study of TNB-486, a Bispecific Antibody Targeting CD19 in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Disease Site: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 21126
A Phase 1 Open-label, Multicenter Study Evaluating the Safety of KITE-222, an Autologous Anti-CLL-1 CAR T-cell Therapy, in Subjects with Relapsed/Refractory Acute Myeloid Leukemia
Disease Site: Leukemia, other
View Trial DetailsCLINICAL TRIAL 21129
A Phase 1/1b, Open-Label, Multicenter, Dose-Escalation Study of RMC-5552 Monotherapy in Adult Subjects with Relapsed/Refractory Solid Tumors
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 21131
A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21135
Randomized, Placebo-Controlled, Phase II Trial Examining Ustekinumab for Prevention of Graft vs. Host Disease after Allogeneic Hematopoietic Cell Transplantation
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 21136
Phase 2 Clinical Trial of Radiomic Habitat-Directed Radiation Dose Escalation for High-Grade Soft Tissue Sarcoma
Disease Site: Soft Tissue
View Trial DetailsCLINICAL TRIAL 21139
A Phase IIA Study of Sequential ("first strike, second strike") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for High Risk Metastatic Castration Sensitive Prostate Cancer
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 21140
Phase I Trial With Expansion Cohort Of DNA-PK Inhibition And IMRT In Cisplatin-Ineligible Patients With Stage 3-4 Local-Regionally Advanced Head And Neck Squamous Cell Carcinoma (HNSCC)
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21157
A Phase I/Ib Open-Label, Multi-Center, Dose-Escalation Study To Investigate The Safety, Pharmacokinetics And Preliminary Efficacy Of Intravenous NBF-006 In Patients With Non-Small Cell Lung, Pancreatic, Or Colorectal Cancer Followed By A Dose Expansion Study In Patients With KRAS-Mutated Non-Small Cell Lung Cancer
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 21160
A Phase 1b/2 Study of the Dual MDMX/MDM2 Inhibitor, ALRN-6924, for the Prevention of Chemotherapy-induced Myelosuppression
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 21163
A Phase 1/2 Study of Regn7075 (Egfrxcd28 Costimulatory Bispecific Antibody) in Combination with Cemiplimab in Patients with Advanced Solid Tumors
Disease Site: Anus, Breast, Cervix, Colon, Esophagus, Kidney, Lip, Oral Cavity and Pharynx, Lung, Other Digestive Organ, Other Female Genital, Other Male Genital, Other Skin, Other Urinary, Pancreas, Prostate, Stomach
View Trial DetailsCLINICAL TRIAL 21167
A Phase 1/2 Open-label Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 21178
An investigator-initiated Phase I study of SELINEXOR in combination with Bevacizumab and Atezolizumab in newly diagnosed advanced Hepatocellular Carcinoma
Disease Site: Liver
View Trial DetailsCLINICAL TRIAL 21179
A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes (TILs) in Subjects with Advanced Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 21180
A First-in-Human, Two-Part, Open-Label, Clinical Study to Assess the Safety, Tolerability and Activity of Intravenous Doses of ICT01 as Monotherapy and in Combination with an Immune Checkpoint Inhibitor, in Patients with Advanced-Stage, Relapsed/Refractory Cancer (EVICTION Study)
Disease Site: Any Site, Breast, Colon, Larynx, Leukemia, other, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Ovary, Prostate, Stomach, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 21186
ACCESS: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies
Disease Site: Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 21193
Pre-operative Hypofractionated Stereotactic Radiosurgery for Resectable Brain Metastases
Disease Site: Brain and Nervous System, Brain metastasis
View Trial DetailsCLINICAL TRIAL 21196
A Phase 1 First-in Human, Multi-Center, Open Label Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 21199
A Phase 3, Randomized, Double-Blind Study of Trilaciclib or Placebo in Patients Receiving First- or Second-Line Gemcitabine and Carboplatin Chemotherapy for Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (PRESERVE 2)
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21201
A Phase 1b/2 Dose Escalation and Expansion Study of Tucatinib in Combination with Trastuzumab and Oxaliplatin-Based Chemotherapy for HER2+ Gastrointestinal Cancers
Disease Site: Colon, Esophagus, Liver, Rectum, Stomach
View Trial DetailsCLINICAL TRIAL 21222
Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated With First-Line Mk-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist s/Patient s Choice) A171901
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 21227
A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (GIANT)
Disease Site: Pancreas
View Trial DetailsCLINICAL TRIAL 21228
A Phase 1/2 Open-Label, Dose-Escalation and Clinical Response Study of Quaratusugene Ozeplasmid in Combination with Pembrolizumab versus Docetaxel with or without Ramucirumab in Patients with Previously Treated Non-Small Cell Lung Cancer (Acclaim 2)
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 21239
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 21240
An open label, multi-center Phase IIIb study of asciminib (ABL001) monotherapy in previously treated patients with chronic myeloid leukemia in chronic phase (CML-CP) with and without T315I mutation (AIM4CML)
Disease Site: Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 21249
A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21255
STEEL: A Randomized Phase II Trial of Salvage Radiotherapy with Standard vs Enhanced Androgen Deprivation Therapy (with Enzalutamide) in Patients with Post-Prostatectomy PSA Recurrences with Aggressive Disease Features
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 21257
A Phase 1 First-in-Human Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Solid Tumors
Disease Site: Breast, Lung
View Trial DetailsCLINICAL TRIAL 21279
A Phase 3, Randomized, Double-Blind, Active- Control Study of CPI-0610 and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients
Disease Site: Bones and Joints, Myelofibrosis
View Trial DetailsCLINICAL TRIAL 21282
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21344
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients with Melanoma (Morpheus-Melanoma)
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 21378
Phase 1 Study of Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine and Pepinemab / Trastuzumab in Patients with Metastatic HER2-Positive Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21383
A Prospective, Randomized, Controlled, Open-label, Multicenter Trial to Evaluate Efficacy, Safety and Patient-reported Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium (177Lu) Edotreotide compared to Best Standard of Care in Patients with Well-differentiated Aggressive Grade 2 and Grade 3, Somatostatin Receptor-positive (SSTR+), Neuroendocrine Tumors of GastroEnteric or Pancreatic Origin (COMPOSE)
Disease Site: Other Digestive Organ, Other Endocrine System
View Trial DetailsCLINICAL TRIAL 21399
Phase I Study of MEM-288 Oncolytic Virus in Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC)
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 21460
Phase Ib Trial of Erdafitinib Combined with Enfortumab Vedotin Following Platinum and PD1/L1 Inhibitors for Metastatic Urothelial Carcinoma with FGFR2/3 Genetic Alterations
Disease Site: Other Urinary
View Trial DetailsCLINICAL TRIAL 21518
A Phase 1/1b Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of KIN-2787 in Participants with BRAF and/or NRAS Mutation Positive Solid Tumors
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 21534
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 21573
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients with Hepatic Dominant Ocular Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 21641
First-in-Human, Phase 1/1b, Open-label, Multicenter Study of Bifunctional EGFR/TGF_ Fusion Protein BCA101 Alone and in Combination with Pembrolizumab in Patients With EGFR-Driven Advanced Solid Tumors
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21657
Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21665
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine And Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
Disease Site: Other Digestive Organ, Pancreas
View Trial DetailsCLINICAL TRIAL 21712
A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in PRRT Naïve Subjects with Somatostatin Receptor Expressing Neuroendocrine Tumors
Disease Site: Any Site, Liver, Lung, Other Digestive Organ, Other Endocrine System, Pancreas, Rectum, Small Intestine, Stomach
View Trial DetailsCLINICAL TRIAL 21728
A Phase I/II Study of TTI-621 in Combination with Doxorubicin in Patients with Unresectable or Metastatic High-Grade Leiomyosarcoma
Disease Site: Soft Tissue
View Trial DetailsCLINICAL TRIAL 21761
A Phase 1 First-in-Human Dose-escalation and Dose-expansion Study of BMF-219, an Oral Irreversible Menin Inhibitor, in Adult Patients with Acute Leukemia Including Those with an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Disease Site: Lymphoid Leukemia, Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 90001
A Phase 2, Multicenter, Single-Arm Study of Retreatment with Brentuximab Vedotin in Subjects with Relapsed or Refractory Classic Hodgkin lymphoma (cHL) or CD30-Expressing Peripheral T Cell Lymphoma (PTCL)
Disease Site: Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 90005
Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 90007
Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 90009
A Multicentre, Open-label, Non-randomised First in Human Study of NG-641, an Oncolytic Transgene Expressing Adenoviral Vector, in Patients With Metastatic or Advanced Epithelial Tumours (STAR)
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 90010
A Phase 1/1B, Open-Label, Dose Escalation and Expansion Study of SBT6050 Alone and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors Expressing HER2
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 90015
Phase 1 First-in-Human (FIH) Study of Leukocyte Immunoglobulin-Like Receptor B2 (LILRB2) Inhibitor Monoclonal Antibody (mAb) JTX-8064, as Monotherapy and in Combination with a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, in Adult Subjects with Advanced Refractory Solid Tumor Malignancies
Disease Site: Breast, Lung, Melanoma, skin, Ovary, Pancreas, Urinary Bladder
View Trial DetailsCLINICAL TRIAL 19731
Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator Intervention for Neuro-Oncology Couples
Disease Site: Brain and Nervous System, Brain metastasis, Gliomas, Leptomeningeal (LMD), Meningiomas
View Trial DetailsCLINICAL TRIAL 20067
INSPIRE: A Multicenter Randomized Controlled Trial Integrating Health Informatics in a Scalable Stepped Care Self-Management Program for Survivors after Hematopoietic Cell Transplantation
Disease Site: Hodgkin's Lymphoma, Leukemia, other, Lymphoid Leukemia, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Hematopoietic
View Trial DetailsCLINICAL TRIAL 20397
A Phase 2 Study of Itacitinib, for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
Disease Site: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20479
Efficacy of SOAR (Survivors Overcoming and Achieving Resiliency) Survivorship Workshop for Breast Cancer Survivors
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 20551
Bright IDEAS-Young Adults: Problem-Solving Skills Training to Reduce Distress Among Young Adults with Cancer
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 20561
Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies
Disease Site: Other Digestive Organ
View Trial DetailsCLINICAL TRIAL 21150
Effect of Prolonged Nightly Fasting (PNF) on Immunotherapy Treatment Outcomes in Patients with Advanced Head and Neck Cancer (HNSCC)-Role of Gut Microbiome
Disease Site: Larynx, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21795
Early Supportive Care and Nutritional Support in Adults with Pancreatic Cancer.
Disease Site: Pancreas
View Trial DetailsCLINICAL TRIAL 21889
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
Disease Site: Esophagus
View Trial DetailsCLINICAL TRIAL 19103
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
Disease Site: Colon, Rectum
View Trial DetailsCLINICAL TRIAL 19305
CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease
Disease Site: Other hematologic, Unknown Sites, Leukemia, other
View Trial DetailsCLINICAL TRIAL 19622
Phase II Trial of Investigational Agents to Modulate Intermediate Endpoint Biomarkers, Including Pulmonary Nodules, in Former and Current Smokers
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 20154
Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers
Disease Site: Other
View Trial DetailsCLINICAL TRIAL 20337
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living with HIV
Disease Site: Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 21224
Determining the Structural- and Functional-Level Effects of Diet-specific Interventions on The Gut Microbiota of a Diverse Sample of Southern United States Adults
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 21236
Improving Weight Loss Outcomes of Black Women Using a Culturally-Relevant Stress-Management Enhanced Behavioral Weight Loss Intervention
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 19291
The Utility of PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men with High GC Decipher® Test Scores: A Sub-aim of the VANDAAM Study (MCC #18523)
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 19844
A Pre-Pilot of a Survivor-Personalized Colorectal Cancer Screening Education Intervention for Adult First-Degree Relatives
Disease Site: Colon, Rectum
View Trial DetailsCLINICAL TRIAL 19974
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow and the Surrounding Hepatic Parenchyma before, during and after Hepatic Artery Embolization
Disease Site: Liver
View Trial DetailsCLINICAL TRIAL 20601
CARES-HCV: Promoting Concurrent Hepatitis C Virus Screening and Colorectal Cancer Screening Uptake Among Diverse Baby Boomers
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 20786
Efficacy Of A Mindfulness-Based Stress Management Program For Allogeneic HCT Caregivers
Disease Site: Other Hematopoietic
View Trial DetailsCLINICAL TRIAL 21235
Clinical Trials Outreach & Education
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 21081
Assessing Distress in Family Caregivers of Patients Receiving Cellular Therapies
Disease Site: Leukemia, other
View Trial DetailsCLINICAL TRIAL 21751
C-PRIME: Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life
Disease Site: Other
View Trial DetailsCLINICAL TRIAL 21355
Prospective Cohort Study Of The Immune Response To Severe Acute Respiratory Coronavirus 2 (SARS-Cov2) In Oncology Workers: Protect Covid-19 Study
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 14690
Total Cancer Care Protocol: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 15768
Total Lung Care (TLC): Epidemiology of Lung Cancer
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 16028
Transdisciplinary Research in Colorectal Cancer: The ColoCare Study
Disease Site: Colorectal, Colon, Rectum
View Trial DetailsCLINICAL TRIAL 16933
Older Breast Cancer Patients: Risk For Cognitive Decline
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 17716
A Biomarker-related Approach to Screening for HPV-related Oropharyngeal Cancer
Disease Site: Larynx, Throat, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 17723
Expansion of Enduring Infrastructure to Support Lung Cancer Screening Research
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 18523
A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men with Prostate Cancer (VANDAAM Study)
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 18926
The National Myelodysplastic Syndromes (MDS) Study
Disease Site: Leukemia, other, Lymphoid Leukemia, Multiple Myeloma, Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 19209
Combined Imaging and Blood Biomarkers for Breast Cancer Diagnosis
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 19681
Community Outreach: Novel Tracking of INdividuals to Understand and Assess Results (CONTINUAR)
Disease Site: Other
View Trial DetailsCLINICAL TRIAL 19943
Somatostatin receptor expression in poorly-differentiated neuroendocrine carcinomas of the GI tract: analysis using 68Ga-dotatate PET scan
Disease Site: Pancreas, Gastrointestinal, Neuroendocrine, Other Endocrine System, Unknown Sites
View Trial DetailsCLINICAL TRIAL 20010
IRONMAN: International Registry for Men with Advanced Prostate Cancer
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 20105
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas and Uncover Hidden Biology
Disease Site: Pancreas
View Trial DetailsCLINICAL TRIAL 20156
Mindfulness in AYA Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pilot Proposal
Disease Site: Multiple Myeloma, Unknown Sites, Leukemia, other
View Trial DetailsCLINICAL TRIAL 20256
CemiplimAb Survivorship Epidemiology (CASE) Study
Disease Site: Squamous Cell Carcinoma (SCC), Other Skin
View Trial DetailsCLINICAL TRIAL 20372
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
Disease Site: Non-Hodgkin's Lymphoma
View Trial DetailsCLINICAL TRIAL 20585
Development of a Quality of Life Decision-Making Model for Older Patients with Acute Myeloid Leukemia
Disease Site: Acute Leukemia (ALL, AML), Myeloid and Monocytic Leukemia
View Trial DetailsCLINICAL TRIAL 20788
An Advanced MRI Abdomen Protocol to Evaluate Pancreatic Ductal Adenocarcinoma in Surgically Resectable and Borderline Resectable Disease for Loco-Regional Heterogeneity and To Evaluate Treatment Response Status Post Surgery and MRI-GRT
Disease Site: Pancreas
View Trial DetailsCLINICAL TRIAL 20816
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 20819
Adaptation of an HPV education resource to promote HPV vaccination among Latino Young Men who Have Sex with Men in Puerto Rico and Florida (Proyecto Hombres Previniendo el VPH (Proyecto HPV)
Disease Site: Anus, Cervix, Lip, Oral Cavity and Pharynx
View Trial DetailsCLINICAL TRIAL 20853
Health Beliefs, Behaviors, and Healthcare Experiences among a National Sample of United States Young and Mid-Age Adults
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 20888
Predicting the Quality of Response to Specific Treatments (PQRST) Chronic GVHD Cohort
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 21183
The EDUCATE Initiative A Multimodal Campaign to Enhance Provider-Patient Awareness of CTCL Disparities in Skin of Color
Disease Site: Other Skin
View Trial DetailsCLINICAL TRIAL 21184
Thoracic Program Trial Selection Protocol
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 21233
The PAWN-Q Study: An Exploratory Analysis of Perceived Needs Regarding Physical Activity, Appearance, Weight, Nutrition, and Quality of Life in Adolescent and Young Adult Cancer Survivors
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 21261
Characterizing the Gut Microbiome in Cancer Patients with Underlying HIV Infection
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 21268
Biobanking for Breast Cancer Prevention and Disparity Research in Florida
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 21353
A Prospective Randomized Trial Comparing Pre-Anesthesia Evaluation Remotely via Telemedicine Versus in Person for Surgical Patients at H. Lee Moffitt Cancer Center
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 21448
Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21461
Patient Activation Toolkit for HCV Screening (PATHS)
Disease Site: Other
View Trial DetailsCLINICAL TRIAL 21592
An Exploration of Interventions to Address Mistrust as a Barrier to Clinical Trial Participation Among African Americans: Use of the Social-Ecological Model (SEM)
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 21610
The Influence of Psychosocial Factors on Opioid Decision-Making among Breast Cancer Survivors
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21737
A Pilot Study of Advanced Multi-parametric MRI to Evaluate De Novo Glioblastoma Tumors Prior to Surgical Resection
Disease Site: Brain and Nervous System, Gliomas
View Trial DetailsCLINICAL TRIAL 21786
The "COACH" Study: Individualized COaching in Young Adult Cancer Survivors to Encourage Healthy Behaviors
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 21876
Exploring Men s Prostate Cancer Genetic Risk Perceptions and Willingness to Give a Biospecimen for Genetic Risk Testing
Disease Site: Prostate
View Trial DetailsCLINICAL TRIAL 17971
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 19000
Evaluation of Anti-Her2 and Anti-Her3 T-Helper Response in Primary Breast Cancer
Disease Site: Breast - Female
View Trial DetailsCLINICAL TRIAL 19724
Managed Access Program (MAP) To Provide Access To CTL019, For Acute Lymphoblastic Leukemia (ALL) Or Diffuse Large B-Cell Lymphoma (DLBCL) Patients With Out Of Specification Leukapheresis Product And/Or Manufactured Tisagenlecleucel Out Of Specification For Commercial Release
Disease Site: Acute Leukemia (ALL, AML), Leukemia, other
View Trial DetailsCLINICAL TRIAL 19950
Linking the Skin and Gut Microbiome to Immunosuppression in Skin Cancer
Disease Site: Other Skin
View Trial DetailsCLINICAL TRIAL 20003
LungMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer(Lung-MAP Screening Study)
Disease Site: Lung, Non small cell lung cancer
View Trial DetailsCLINICAL TRIAL 20187
Development of Intra-tumor Driver Mutation Prevalence as a Predictor of Efficacy of Targeted Agents
Disease Site: Reproductive System, Any Site
View Trial DetailsCLINICAL TRIAL 21065
Tumor Stroma in Pancreatic Adenocarcinoma
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 21125
MElanoma Research Lymph Node Prediction Implementation National_001 (MERLIN_001)
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 21164
Radiomics and Pathomics to Predict Upstaging of DCIS
Disease Site: Breast
View Trial DetailsCLINICAL TRIAL 21219
Predicting Progression of Developing Myeloma in a High-Risk Screened Population
Disease Site: Multiple Myeloma
View Trial DetailsCLINICAL TRIAL 21266
Gut Metabolome-Can it be Developed As A Biomarker of Response to Immunotherapy in Metastatic Renal Cell Cancer
Disease Site: Kidney
View Trial DetailsCLINICAL TRIAL 21351
A Prospective Analysis of Biochemical Markers for Hematopoietic Cell Transplant-Associated Thrombotic Microangiopathy in Adults
Disease Site: Unknown Sites
View Trial DetailsCLINICAL TRIAL 50401
Creation of Cell Lines and Corresponding DNA and RNA Analysis from Acral Lentiginous Malignant Melanoma
Disease Site: Melanoma, skin
View Trial DetailsCLINICAL TRIAL 50428
Metabolite Consumption in Patient-Derived Explants to Predict Therapeutic Response in Aggressive and Oligometastatic Prostate Cancer in African American Men
Disease Site: Prostate
View Trial Details
